Common diabetes drug tested to protect HIV Patients' brains
NCT ID NCT05571319
Summary
This small pilot study tested whether metformin, a common and affordable diabetes medication, could improve blood vessel function and blood flow in the brains of people living with HIV who also have metabolic syndrome. The researchers enrolled 30 participants in South Africa who took metformin for 12 weeks. The goal was to see if this well-known drug could help reduce brain blood vessel damage and inflammation linked to a higher risk of future memory problems and dementia.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METABOLIC SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Desmond Tutu Health Foundation: Gugulethu Research Site
Cape Town, Western Cape, 8001, South Africa
Conditions
Explore the condition pages connected to this study.